The challenges of introducing routine G6PD testing into radical cure: A workshop report
© 2015 Ley et al. The only currently available drug that effectively removes malaria hypnozoites from the human host is primaquine. The use of 8-aminoquinolines is hampered by haemolytic side effects in glucose-6-phosphate dehydrogenase (G6PD) deficient individuals. Recently a number of qualitative...
Saved in:
Main Authors: | Benedikt Ley, Nick Luter, Fe Esperanza Espino, Angela Devine, Michael Kalnoky, Yoel Lubell, Kamala Thriemer, J. Kevin Baird, Eugenie Poirot, Nolwenn Conan, Chong Chee Kheong, Lek Dysoley, Wasif Ali Khan, April G. Dion-Berboso, Germana Bancone, Jimee Hwang, Ritu Kumar, Ric N. Price, Lorenz Von Seidlein, Gonzalo J. Domingo |
---|---|
Other Authors: | Menzies School of Health Research |
Format: | Article |
Published: |
2018
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/36072 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Methods for the field evaluation of quantitative G6PD diagnostics: A review
by: Benedikt Ley, et al.
Published: (2018) -
Towards the elimination of Plasmodium vivax malaria: Implementing the radical cure
by: Kamala Thriemer, et al.
Published: (2022) -
G6PD Variants and Haemolytic Sensitivity to Primaquine and Other Drugs
by: Germana Bancone, et al.
Published: (2022) -
Precarity at the margins of malaria control in the chittagong hill tracts in bangladesh: A mixed-methods study
by: Mohammad Abdul Matin, et al.
Published: (2020) -
Investment in malaria elimination: a leap of faith in need of direction.
by: Lubell, Yoel
Published: (2014)